Accessibility Menu
 
Atomo Diagnostics logo

Atomo Diagnostics

(ASX) AT1

Current Price$0.03
Market Cap$23.50M
Since IPO (2020)-93%
5 Year-88%
1 Year+53%
1 Month-22%

Atomo Diagnostics Financials at a Glance

Market Cap

$23.50M

Revenue (TTM)

$8.14M

Net Income (TTM)

$10.43M

EPS (TTM)

$-0.01

P/E Ratio

-5.18

Dividend

$0.00

Beta (Volatility)

0.10 (Low)

Price

$0.03

Volume

336,398

Open

$0.03

Previous Close

$0.03

Daily Range

$0.03 - $0.03

52-Week Range

$0.01 - $0.05

AT1 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Atomo Diagnostics

Industry

Healthcare Equipment and Supplies

CEO

John Kelly, EMBA

Headquarters

Leichhardt, NSW 2040, AU

AT1 Financials

Key Financial Metrics (TTM)

Gross Margin

-10%

Operating Margin

-1%

Net Income Margin

-1%

Return on Equity

-57%

Return on Capital

-66%

Return on Assets

-42%

Earnings Yield

-19.31%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$23.50M

Shares Outstanding

810.17M

Volume

336.40K

Short Interest

0.00%

Avg. Volume

2.17M

Financials (TTM)

Gross Profit

$1.79M

Operating Income

$3.81M

EBITDA

$4.69M

Operating Cash Flow

$1.96M

Capital Expenditure

$33.89K

Free Cash Flow

$1.99M

Cash & ST Invst.

$3.22M

Total Debt

$185.10K

Atomo Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.18M

+13.4%

Gross Profit

$1.28M

+44.2%

Gross Margin

-58.55%

N/A

Market Cap

$23.50M

N/A

Market Cap/Employee

$276.41K

N/A

Employees

85

N/A

Net Income

$1.76M

+44.0%

EBITDA

$2.08M

+25.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$2.76M

-56.5%

Accounts Receivable

$1.86M

+42.1%

Inventory

$1.61M

-11.3%

Long Term Debt

$507.75K

N/A

Short Term Debt

$246.64K

-28.1%

Return on Assets

-41.95%

N/A

Return on Invested Capital

-66.44%

N/A

Free Cash Flow

$1.01M

+46.5%

Operating Cash Flow

$962.50K

+48.9%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IDT.AXIDT Australia Limited
$0.04+0.00%
CBL.AXControl Bionics Limited
$0.06+0.00%
AGH.AXAlthea Group Holdings Limited
$0.02-4.76%
NTI.AXNeurotech International Limited
$0.01+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$61.72+0.05%
NVDANvidia
$183.91+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.45+0.02%
NOKNokia
$9.55+0.01%

Questions About AT1

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.